Conduct phase III clinical study on resistant hypertension: CDSCO Panel tells Sun Pharmaceutical Industries on Esaxerenone Dr. Divya Colin8 Dec 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Sun Pharmaceutical Industries to manufacture and market the drug Esaxerenone tablets...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study Ranibizumab Solution for Injection Dr. Divya Colin9 Nov 2024 5:30 PM ISTNew Delhi: The drug major Sun Pharmaceutical Industries has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharmaceutical Industry gets CDSCO Panel nod to study Aflibercept Injection Dr. Divya Colin6 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
NPPA Fixes Retail Prices of 62 Formulations, Details Susmita Roy14 Sept 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of...
Sun Pharmaceutical Industry gets CDSCO Panel nod to study Fexuprazan HCL tablet for erosive esophagitis Dr. Divya Colin11 Aug 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the Sun Pharmaceutical Industry to manufacture and market the Fexuprazan Hydrochloride tablet, the...
Sun Pharma Industries Gets CDSCO Panel Nod to assess safety and efficacy of Relugolix Tablets for advanced prostate cancer Dr. Divya Colin24 Jun 2024 6:00 PM ISTNew Delhi: In order to assess the safety and efficacy of Relugolix Tablets 120 mg indicated for the treatment of advanced prostate cancer, the Subject...
NPPA authority rejects Sun Pharmaceuticals application for separate ceiling price for Antibiotic Suspension Dual Chamber Pack with novel technology Dr. Divya Colin23 Jun 2024 6:00 PM ISTNew Delhi: Observing that there is no data or evidence in the survey report that shows reduction in reconstitution time and spillage as claimed, the...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Sun Pharma gets USFDA nod for neonatal seizures treatment SEZABY Ruchika Sharma18 Nov 2022 12:15 PM ISTSEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.
DoP directs NPPA to examine ceiling price of Sun Pharma hypertension drug Diltiazem Medical Dialogues Bureau9 Aug 2020 11:30 AM ISTNew Delhi: Upholding Sun Pharmaceuticals Ltd. (Sun Pharma) review petition, the Department of Pharmaceuticals (DOP), recently directed the National...
Sun Pharma arm resolves US antitrust case over generic drug pricing, to pay Rs 1542 crore Farhat Nasim25 July 2020 11:09 AM ISTMumbai: Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with...
